Drug Patent Expirations in July 2012

Tradename	Applicant	Generic Name	Patent Number	Patent Expiration
JEVTANA KIT	Sanofi Aventis Us	cabazitaxel	5698582	Jul 3, 2012
ISTODAX	Celgene	romidepsin	4977138	Jul 6, 2012
NEUROLITE	Lantheus Medcl	technetium tc-99m bicisate kit	5431900	Jul 11, 2012
CERVIDIL	Controlled Therap	dinoprostone	5269321	Jul 14, 2012
RESCULA	Sucampo Pharms	unoprostone isopropyl	5221763	Jul 15, 2012
MULTAQ	Sanofi Aventis Us	dronedarone hydrochloride	5223510	Jul 26, 2012
EVISTA	Lilly	raloxifene hydrochloride	6906086	Jul 28, 2012
EVISTA	Lilly	raloxifene hydrochloride	RE38968	Jul 28, 2012
EVISTA	Lilly	raloxifene hydrochloride	5393763	Jul 28, 2012
EVISTA	Lilly	raloxifene hydrochloride	RE39049	Jul 28, 2012
EVISTA	Lilly	raloxifene hydrochloride	5457117	Jul 28, 2012
LAMICTAL CD	Glaxosmithkline	lamotrigine	5698226*PED	Jul 29, 2012
ETHYOL	Medimmune	amifostine	5424471	Jul 31, 2012
ETHYOL	Medimmune	amifostine	5591731	Jul 31, 2012
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.